Please join me and my esteemed colleagues—leading lights of integrative oncology—for the Healing Cancer World Summit, which airs starting October 27.
Glenn shares how THC and CBD are being used in a clinical setting—and where we are in terms of current science supporting medical marijuana and CBD oil for symptom relief and as an anticancer agent. He also shares his own history with cannabinoids.
Guest post by Dr. Nancy Novack–a clinical psychologist, cancer thriver, and expert on all things cancer financial matters–shares important resources that all patients, oncologists, and healthcare professionals should be aware of to lessen the burden of cancer.
Glenn explores the phenomena of cancer outliers, exceptional responders and radical remissions in the age of precision medicine, biomedical informatics and integrative oncology.
A recently published paper in the esteemed JAMA Oncology triggered dire headlines, including this one in The New York Times:
“People who used herbs, acupuncture and other complementary treatments tended to die earlier than those who didn’t.”
Really? Is this true?
We enrolled dad into in-home hospice a couple weeks ago. It’s been a challenging process. Mine is a nuclear family of five, nine different cancers between us. No one has yet succumbed to the disease.
For 20 years, the Environmental Working Group (EWG) has been the stalwart investigative organization scrutinizing unsafe chemicals and toxins in our food, water, cosmetics, and cleaning products.
Given the easy access to direct-to-consumer (DTC) DNA testing, it is vital to discern the potential value versus possible emotional and physical risks that having such data might present.
Investigation of the human microbiome has grown exponentially in the last five years. A recent study regarding its potential impact on certain cancer treatment outcomes stopped me in my tracks. The human body contains about 40 trillion microbes, which is now thought to equal the total volume of human cells each body possesses. These bugs […]
The Right-to-Try movement—advocates for faster access to potentially life-saving experimental drugs for terminal patients—has gained strong momentum, with the act recently winning easy passage in congress, and, at the time of this article, it is on its way for a senate vote. The legislation is widely anticipated to become law later this year. As of […]